The role and outcomes of palliative surgery for retroperitoneal sarcoma

The role and outcomes of palliative surgery for retroperitoneal sarcoma INTRODUCTIONIn a sense, the majority of surgical procedures performed in patients with retroperitoneal sarcoma (RPS) could be regarded as “palliative.” Large surgical series with long‐term follow‐up have shown that while the recurrence rate is highest within the first two years following complete resection of primary RPS, recurrences continue to occur 15‐20 years later, with no apparent plateau. The very long‐term recurrence‐free survival rate is less than 25% in such series. For recurrent RPS, whether local or distant, the disease‐specific survival rates following resection are worse still. However, recent improvements in the quality of surgical resection may translate to improved long‐term outcomes. In keeping with the latter expectation, a consensus statement by the Trans‐Atlantic RPS working group (TARPSWG) emphasizes that the best chance of curative resection is at time of primary presentation, with discussion of every patient at a multidisciplinary sarcoma conference where adjuvant therapies can be considered as the optimal approach to “curative‐intent” management is developed for the individual patient. By contrast, the role of surgery in patients who are not eligible for a curative approach is fraught with uncertainty and controversy.The term “palliative care” was first coined in 1975 by Balfour Mount, a Canadian urologist who started a http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Journal of Surgical Oncology Wiley

The role and outcomes of palliative surgery for retroperitoneal sarcoma

Loading next page...
 
/lp/wiley/the-role-and-outcomes-of-palliative-surgery-for-retroperitoneal-w1l9Tp92YL
Publisher
Wiley
Copyright
© 2018 Wiley Periodicals, Inc.
ISSN
0022-4790
eISSN
1096-9098
D.O.I.
10.1002/jso.24934
Publisher site
See Article on Publisher Site

Abstract

INTRODUCTIONIn a sense, the majority of surgical procedures performed in patients with retroperitoneal sarcoma (RPS) could be regarded as “palliative.” Large surgical series with long‐term follow‐up have shown that while the recurrence rate is highest within the first two years following complete resection of primary RPS, recurrences continue to occur 15‐20 years later, with no apparent plateau. The very long‐term recurrence‐free survival rate is less than 25% in such series. For recurrent RPS, whether local or distant, the disease‐specific survival rates following resection are worse still. However, recent improvements in the quality of surgical resection may translate to improved long‐term outcomes. In keeping with the latter expectation, a consensus statement by the Trans‐Atlantic RPS working group (TARPSWG) emphasizes that the best chance of curative resection is at time of primary presentation, with discussion of every patient at a multidisciplinary sarcoma conference where adjuvant therapies can be considered as the optimal approach to “curative‐intent” management is developed for the individual patient. By contrast, the role of surgery in patients who are not eligible for a curative approach is fraught with uncertainty and controversy.The term “palliative care” was first coined in 1975 by Balfour Mount, a Canadian urologist who started a

Journal

Journal of Surgical OncologyWiley

Published: Jan 1, 2018

Keywords: ; ; ;

References

You’re reading a free preview. Subscribe to read the entire article.


DeepDyve is your
personal research library

It’s your single place to instantly
discover and read the research
that matters to you.

Enjoy affordable access to
over 18 million articles from more than
15,000 peer-reviewed journals.

All for just $49/month

Explore the DeepDyve Library

Search

Query the DeepDyve database, plus search all of PubMed and Google Scholar seamlessly

Organize

Save any article or search result from DeepDyve, PubMed, and Google Scholar... all in one place.

Access

Get unlimited, online access to over 18 million full-text articles from more than 15,000 scientific journals.

Your journals are on DeepDyve

Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.

All the latest content is available, no embargo periods.

See the journals in your area

DeepDyve

Freelancer

DeepDyve

Pro

Price

FREE

$49/month
$360/year

Save searches from
Google Scholar,
PubMed

Create lists to
organize your research

Export lists, citations

Read DeepDyve articles

Abstract access only

Unlimited access to over
18 million full-text articles

Print

20 pages / month

PDF Discount

20% off